Management of high-risk squamous cell carcinoma of the skin

Expert Review of Anticancer Therapy

Volumn 11, Issue 5, 2011, Pages 763-769

  Samarasinghe, Venura ^a   Madan, Vishal ^a   Lear, John T ^a  

^a HOPE HOSPITAL   (United Kingdom)

Author keywords

high risk; management; metastasis; SCC; skin cancer; squamous cell carcinoma

Indexed keywords

ANTINEOPLASTIC AGENT; IMMUNOMODULATING AGENT; RETINOID;

ADVANCED CANCER; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHEMOSURGERY; COMPUTER ASSISTED TOMOGRAPHY; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; IMMUNE DEFICIENCY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT IDENTIFICATION; PERINEURIUM; RADIATION INJURY; REVIEW; SKIN CARCINOGENESIS; SKIN CARCINOMA; SKIN FLAP; SQUAMOUS CELL CARCINOMA; SUN EXPOSURE; SUNLIGHT PROTECTION; TUMOR DIFFERENTIATION; TUMOR LOCALIZATION; TUMOR VOLUME; ULTRAVIOLET RADIATION;

CARCINOMA, SQUAMOUS CELL; HEAD AND NECK NEOPLASMS; HUMANS; NEOPLASM METASTASIS; RISK FACTORS; SKIN NEOPLASMS; SURVIVAL RATE; ULTRAVIOLET RAYS;

EID: 79955826759     PISSN: 14737140     EISSN: 17448328     Source Type: Journal    
DOI: 10.1586/era.11.36     Document Type: Review

References (26)

1. McGuire JF, Ge NN, Dyson S. Nonmelanoma skin cancer of the head and neck I: histopathology and clinical behaviour. Am. J. Otolaryngol. 30(2) 121-133, (2009).
2. Alam M, Ratner D. Cutaneous squamous-cell carcinoma. N. Engl. J. Med. 344(13), 975-983 (2001).
3. Leibovitch I, Huilgol SC, Selva D, Richards S, Paver R. Cutaneous squamous cell carcinoma treated with Mohs micrographic surgery in Australia I. Experience over 10 years. J. Am. Acad. Dermatol. 53(2), 253-260 (2005).
4. Jensen V, Prasad AR, Smith A et al Prognostic criteria for squamous cell cancer of the skin. J. Surg. Res. 159(1), 509-516 (2010).
5. Mourouzis C, Boynton A, Grant J et al Cutaneous head and neck SCCs and risk of nodal metastasis - UK experience. J. Craniomaxillofac. Surg 37(8), 443-447 (2009).
6. Boukamp P. Non-melanoma skin cancer: what drives tumor development and progression? Carcinogenesis 26(10), 1657-1667 (2005).
7. Madan V, Lear JT, Szeimies R. Non-melanoma skin cancer. Lancet 375, 673-685 (2010).
8. Quatresooz P, Pierard-Franchimont C, Paquet P, Hubert P, Delvenne P, Pierard GE. Crossroads between actinic keratosis and squamous cell carcinoma, and novel pharmacological issues. Eur. J. Dermatol. 18(1), 6-10 (2008).
9. de Lima Vazquez V, Sachetto T, Perpetuo NM, Carvalho AL. Prognostic factors for lymph node metastasis from advanced squamous cell carcinoma of the skin of the trunk and extremities. World J. Surg Oncol. 6, 73 (2008).
10. Smoller BR. Squamous cell carcinoma: from precursor lesions to high-risk variants. Mod. Pathol. 19(Suppl. 2), S88-S92 (2006).
11. Rowe DE, Carroll RJ, Day CL Jr. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. J Am. Acad. Dermatol. 26(6), 976-990 (1992).
12. Mullen JT, Feng L, Xing Y et al. Invasive squamous cell carcinoma of the skin: defining a high-risk group. Ann. Surg Oncol. 13(7), 902-909 (2006).
13. Veness MJ, Palme CE, Morgan GJ. High-risk cutaneous squamous cell carcinoma of the head and neck: results from 266 treated patients with metastatic lymph node disease. Cancer 106(11), 2389-2396 (2006).
14. Jennings L, Schmults CD. Management of high-risk cutaneous squamous cell carcinoma.J Clin. Aesthet. Dermatol. 3(4), 39-48(2010).
15. Brantsch KD, Meisner C, Schonfisch B et al. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. Lancet Oncol. 9(8), 713-720 (2008).
16. Cassarino DS, Derienzo DP, Barr RJ. Cutaneous squamous cell carcinoma: a comprehensive clinicopathologic classification: part two. J Cutan. Pathol. 33(4), 261-279 (2006).
17. Moore BA, Weber RS, Prieto V et al. Lymph node metastases from cutaneous squamous cell carcinoma of the head and neck. Laryngoscope 115(9), 1561-1567 (2005).
18. Clayman GL, Lee JJ, Holsinger FC et al. Mortality risk from squamous cell skin cancer.J Clin. Oncol. 23(4), 759-765 (2005).
19. Keller B, Braathen LR, Marti HP, Hunger RE. Skin cancers in renal transplant recipients: a description of the renal transplant cohort in Bern. Swiss Med. Wkly I40,wl3036 (2010).
20. Stasko T, Brown MD, Carucci JA et al Guidelines for the management of squamous cell carcinoma in organ transplant recipients. Dermatol. Surg. 30(4 Pt 2), 642-650 (2004).
21. Edge SE, Byrd DR, Compton CC, Fritz A, Greene FL, Trotti A. AJCC Cancer Staging Manual (7th Edition). Springer, NY, USA (2009).
22. Brodland DG, Zitelli JA. Surgical margins for excision of primary cutaneous squamous cell carcinoma. J. Am. Acad. Dermatol. 27(2 Pt 1), 241-248 (1992).
23. Mohs F. Chemosurgery: a microscopically controlled method of cancer excision. Arch. Surg. 42, 279-295 (1941).
24. Kwan W, Wilson D, Moravan V. Radiotherapy for locally advanced basal cell and squamous cell carcinomas of the skin. Int. J. Radiat. Oncol. Biol. Phys. 60(2), 406-411 (2004).
25. Martinez JC, Otley CC, Okuno SH, Foote RL, Kasperbauer JL. Chemotherapy in the management of advanced cutaneous squamous cell carcinoma in organ transplant recipients: theoretical and practical considerations. Dermatol. Surg 30(4 Pt2), 679-686 (2004).
26. Ross AS, Schmults CD. Sentinel lymph node biopsy in cutaneous squamous cell carcinoma: a systematic review of the English literature. Dermatol. Surg 32(11), 1309-1321 (2006).